| Bioactivity | DL-Laudanosine, an Atracurium and Cisatracurium metabolite, crosses the blood–brain barrier and may cause excitement and seizure activity[1]. | ||||||||||||
| In Vivo | DL-Laudanosine (Laudanosine) appears to be unique in its ability to produce cerebral stimulation in lightly anaesthetized animals and it is reported to cause arousal from anaesthesia in subconvulsive doses[1]. Animal Model: | ||||||||||||
| Name | DL-Laudanosine | ||||||||||||
| CAS | 1699-51-0 | ||||||||||||
| Formula | C21H27NO4 | ||||||||||||
| Molar Mass | 357.44 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. V Fodale, et al. Laudanosine, an Atracurium and Cisatracurium Metabolite. Eur J Anaesthesiol. 2002 Jul;19(7):466-73. [2]. D J Chapple, et al. Cardiovascular and Neurological Effects of Laudanosine. Studies in Mice and Rats, and in Conscious and Anaesthetized Dogs. Br J Anaesth. 1987 Feb;59(2):218-25. |
DL-Laudanosine
CAS: 1699-51-0 F: C21H27NO4 W: 357.44
DL-Laudanosine, an Atracurium and Cisatracurium metabolite, crosses the blood–brain barrier and may cause excitement an
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.